{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T15:52:04Z","timestamp":1790092324229,"version":"4.0.1"},"reference-count":234,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Myopathies represent a highly heterogeneous group of primary muscle disorders, traditionally classified based on clinical presentation and histopathological findings. Recent breakthroughs in molecular genetics, immunology, and pathophysiology have revolutionized the understanding, diagnosis, and management of these conditions. Both inherited and acquired forms of myopathy, including structural, metabolic, inflammatory, endocrine, and mitochondrial subtypes, are now recognized to arise from diverse pathogenic mechanisms such as impaired calcium handling, mitochondrial dysfunction, chronic inflammation, altered metabolism, and defective muscle regeneration. The advent of next-generation sequencing technologies has enabled more precise diagnosis of genetic forms, while the discovery of novel molecular biomarkers and immunological signatures offers promising avenues for disease monitoring and stratification across the broader spectrum. Importantly, molecular and mechanistic insights have redefined clinical classifications, allowing for better prognostic predictions and patient-tailored therapeutic approaches. Innovative treatments, including gene therapy, antisense oligonucleotide therapies, immune-modulating agents, metabolic support strategies, and targeted pharmacological interventions, are progressively translating molecular knowledge into clinical applications. However, technical limitations, biological variability, and ethical considerations continue to pose significant challenges to the implementation of precision medicine in myopathies. In this narrative review, we comprehensively discuss the latest molecular findings, their integration into clinical practice, and the emerging therapeutic strategies based on these discoveries. We also highlight current limitations and propose future research directions aimed at bridging the gap between molecular insights and effective, equitable patient care.<\/jats:p>","DOI":"10.3390\/ijms27031392","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T13:04:46Z","timestamp":1769778286000},"page":"1392","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Molecular Bases of Myopathies and Their Impact on Clinical Practice: Advances and Future Perspectives"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5317-8548","authenticated-orcid":false,"given":"Mart\u00edn","family":"Campuzano-Donoso","sequence":"first","affiliation":[{"name":"Facultad de Ciencias de la Salud y Bienestar Humano, Universidad Tecnol\u00f3gica Indoam\u00e9rica, Ambato 180150, Ecuador"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4234-5524","authenticated-orcid":false,"given":"Claudia","family":"Reytor-Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"Facultad de Ciencias de la Salud y Bienestar Humano, Universidad Tecnol\u00f3gica Indoam\u00e9rica, Ambato 180150, Ecuador"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melannie","family":"Toral-Noristz","sequence":"additional","affiliation":[{"name":"Escuela de Medicina, Universidad Esp\u00edritu Santo, Samborond\u00f3n 0901952, Ecuador"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yamilia","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"Independent Researcher, Santo Domingo 230101, Ecuador"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3641-1501","authenticated-orcid":false,"given":"Daniel","family":"Simancas-Racines","sequence":"additional","affiliation":[{"name":"Facultad de Ciencias de la Salud y Bienestar Humano, Universidad Tecnol\u00f3gica Indoam\u00e9rica, Ambato 180150, Ecuador"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,1,30]]},"reference":[{"key":"ref_1","unstructured":"Malfatti, E., and Romero, N.B. (2018). Diseases of the Skeletal Muscle, Elsevier."},{"key":"ref_2","unstructured":"Nagy, H., and Veerapaneni, K.D. (2025). Myopathy. StatPearls [Internet], StatPearls Publishing."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jns.2017.10.051","article-title":"History and current difficulties in classifying inherited myopathies and muscular dystrophies","volume":"384","author":"Mathis","year":"2018","journal-title":"J. Neurol. Sci."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/rheumatology\/keu289","article-title":"Incidence and prevalence of inflammatory myopathies: A systematic review","volume":"54","author":"Meyer","year":"2015","journal-title":"Rheumatology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/s41584-023-01033-0","article-title":"Epidemiology of the idiopathic inflammatory myopathies","volume":"19","author":"Khoo","year":"2023","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_6","unstructured":"LaPelusa, A., Asuncion, R., and Kentris, M. (2024). Muscular Dystrophy. StatPearls [Internet], StatPearls Publishing."},{"key":"ref_7","first-page":"207","article-title":"LGMD. Identification, description and classification","volume":"39","author":"Angelini","year":"2020","journal-title":"Acta Myol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/s41580-021-00389-z","article-title":"Molecular and cellular basis of genetically inherited skeletal muscle disorders","volume":"22","author":"Dowling","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"322","DOI":"10.7861\/clinmedicine.17-4-322","article-title":"Idiopathic inflammatory myopathies\u2014A guide to subtypes, diagnostic approach and treatment","volume":"17","author":"Oldroyd","year":"2017","journal-title":"Clin. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"8S18","DOI":"10.1016\/S0929-693X(23)00223-3","article-title":"Gene therapy for primary myopathies: Literature review and prospects","volume":"30","author":"Querin","year":"2023","journal-title":"Arch. P\u00e9diatrie"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s13317-014-0062-2","article-title":"Muscle biopsy features of idiopathic inflammatory myopathies and differential diagnosis","volume":"5","author":"Vattemi","year":"2014","journal-title":"Autoimmun. Highlights"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Urtizberea, J.A., Severa, G., and Malfatti, E. (2023). Metabolic Myopathies in the Era of Next-Generation Sequencing. Genes, 14.","DOI":"10.3390\/genes14050954"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1002\/j.2040-4603.2015.tb00638.x","article-title":"The Dystrophin Complex: Structure, Function, and Implications for Therapy","volume":"5","author":"Gao","year":"2015","journal-title":"Compr. Physiol."},{"key":"ref_14","first-page":"498","article-title":"The molecular basis for Duchenne versus Becker muscular dystrophy: Correlation of severity with type of deletion","volume":"45","author":"Koenig","year":"1989","journal-title":"Am. J. Hum. Genet."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0092-8674(87)90504-6","article-title":"Complete cloning of the duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals","volume":"50","author":"Koenig","year":"1987","journal-title":"Cell"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"14","DOI":"10.17305\/bjbms.2015.636","article-title":"Dystrophin and the two related genetic diseases, Duchenne and Becker muscular dystrophies","volume":"15","year":"2015","journal-title":"Biomol. Biomed."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/s42003-022-03980-y","article-title":"The role of the dystrophin glycoprotein complex in muscle cell mechanotransduction","volume":"5","author":"Wilson","year":"2022","journal-title":"Commun. Biol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1242\/jcs.064808","article-title":"Sarcolemmal nNOS anchoring reveals a qualitative difference between dystrophin and utrophin","volume":"123","author":"Li","year":"2010","journal-title":"J. Cell Sci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1002\/humu.21114","article-title":"Mutational spectrum of DMD mutations in dystrophinopathy patients: Application of modern diagnostic techniques to a large cohort","volume":"30","author":"Flanigan","year":"2009","journal-title":"Hum. Mutat."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/0888-7543(88)90113-9","article-title":"An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus","volume":"2","author":"Monaco","year":"1988","journal-title":"Genomics"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Lim, K.R.Q., Nguyen, Q., and Yokota, T. (2020). Genotype\u2013Phenotype Correlations in Duchenne and Becker Muscular Dystrophy Patients from the Canadian Neuromuscular Disease Registry. J. Pers. Med., 10.","DOI":"10.3390\/jpm10040241"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"5952","DOI":"10.1038\/s41598-021-84863-w","article-title":"Low dystrophin variability between muscles and stable expression over time in Becker muscular dystrophy using capillary Western immunoassay","volume":"11","author":"Koeks","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Angulski, A.B.B., Hosny, N., Cohen, H., Martin, A.A., Hahn, D., Bauer, J., and Metzger, J.M. (2023). Duchenne muscular dystrophy: Disease mechanism and therapeutic strategies. Front. Physiol., 14.","DOI":"10.3389\/fphys.2023.1183101"},{"key":"ref_24","first-page":"590","article-title":"Costameres mediate force transduction in healthy skeletal muscle and are altered in muscular dystrophies","volume":"25","author":"Bloch","year":"2004","journal-title":"J. Muscle Res. Cell Motil."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41572-021-00248-3","article-title":"Duchenne muscular dystrophy","volume":"7","author":"Duan","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Jelinkova, S., Fojtik, P., Kohutova, A., Vilotic, A., Markov\u00e1, L., Pesl, M., Jurakova, T., Kruta, M., Vrbsky, J., and Gaillyova, R. (2019). Dystrophin Deficiency Leads to Genomic Instability in Human Pluripotent Stem Cells via NO Synthase-Induced Oxidative Stress. Cells, 8.","DOI":"10.3390\/cells8010053"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/dmcn.15176","article-title":"Peak functional ability and age at loss of ambulation in Duchenne muscular dystrophy","volume":"64","author":"Zambon","year":"2022","journal-title":"Dev. Med. Child. Neurol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/mus.880100212","article-title":"Management of end stage respiratory failure in duchenne muscular dystrophy","volume":"10","author":"Bach","year":"1987","journal-title":"Muscle Nerve"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Gandhi, S., Sweeney, H.L., Hart, C.C., Han, R., and Perry, C.G.R. (2024). Cardiomyopathy in Duchenne Muscular Dystrophy and the Potential for Mitochondrial Therapeutics to Improve Treatment Response. Cells, 13.","DOI":"10.3390\/cells13141168"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/mus.26077","article-title":"Untangling the complexity of limb-girdle muscular dystrophies","volume":"58","author":"Liewluck","year":"2018","journal-title":"Muscle Nerve"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/brain\/77.2.169","article-title":"On the classification, natural history and treatment of the myopathies","volume":"77","author":"Walton","year":"1954","journal-title":"Brain"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Bouchard, C., and Tremblay, J.P. (2023). Limb\u2013Girdle Muscular Dystrophies Classification and Therapies. J. Clin. Med., 12.","DOI":"10.3390\/jcm12144769"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0092-8674(95)90368-2","article-title":"Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A","volume":"81","author":"Richard","year":"1995","journal-title":"Cell"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.nmd.2008.08.005","article-title":"Calpain 3, the \u201cgatekeeper\u201d of proper sarcomere assembly, turnover and maintenance","volume":"18","author":"Beckmann","year":"2008","journal-title":"Neuromuscul. Disord."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"108133","DOI":"10.1016\/j.jbc.2024.108133","article-title":"Human calpain-3 and its structural plasticity: Dissociation of a homohexamer into dimers on binding titin","volume":"301","author":"Ye","year":"2024","journal-title":"J. Biol. Chem."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1111\/j.1742-4658.2006.05351.x","article-title":"Calpain 3: A key regulator of the sarcomere?","volume":"273","author":"Duguez","year":"2006","journal-title":"FEBS J."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"12100","DOI":"10.1073\/pnas.95.21.12100","article-title":"Role of calpain in skeletal-muscle protein degradation","volume":"95","author":"Huang","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.nmd.2006.09.015","article-title":"Painful enlargement of the calf muscles in limb girdle muscular dystrophy type 2B (LGMD2B) with a novel compound heterozygous mutation in DYSF","volume":"17","author":"Diers","year":"2007","journal-title":"Neuromuscul. Disord."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/1682","article-title":"Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy","volume":"20","author":"Liu","year":"1998","journal-title":"Nat. Genet."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.tcb.2004.03.001","article-title":"Dysferlin and the plasma membrane repair in muscular dystrophy","volume":"14","author":"Bansal","year":"2004","journal-title":"Trends Cell Biol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Sun, C., Shen, L., Zhang, Z., and Xie, X. (2020). Therapeutic Strategies for Duchenne Muscular Dystrophy: An Update. Genes, 11.","DOI":"10.3390\/genes11080837"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.3892\/mmr.2014.2048","article-title":"Limb-girdle muscular dystrophies: Where next after six decades from the first proposal (Review)","volume":"9","author":"Mahmood","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Luna-Angulo, A., Landa-Sol\u00eds, C., Escobar-Cedillo, R.E., Estrada-Mena, F.J., S\u00e1nchez-Chapul, L., G\u00f3mez-D\u00edaz, B., Carrillo-Mora, P., Avil\u00e9s-Arnaut, H., Jim\u00e9nez-Hern\u00e1ndez, L., and Jim\u00e9nez-Hern\u00e1ndez, D.A. (2024). Pharmacological Treatments and Therapeutic Targets in Muscle Dystrophies Generated by Alterations in Dystrophin-Associated Proteins. Medicina, 60.","DOI":"10.3390\/medicina60071060"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.nmd.2013.11.003","article-title":"Approach to the diagnosis of congenital myopathies","volume":"24","author":"North","year":"2014","journal-title":"Neuromuscul. Disord."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Gonorazky, H.D., B\u00f6nnemann, C.G., and Dowling, J.J. (2018). The Genetics of Congenital Myopathies, Elsevier.","DOI":"10.1016\/j.nmd.2018.06.170"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1186\/s12967-024-05626-5","article-title":"Congenital myopathies: Pathophysiological mechanisms and promising therapies","volume":"22","author":"Zhang","year":"2024","journal-title":"J. Transl. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1152\/physrev.00033.2020","article-title":"Calcium-release channels: Structure and function of IP3 receptors and ryanodine receptors","volume":"102","author":"Woll","year":"2022","journal-title":"Physiol. Rev."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e2122140119","DOI":"10.1073\/pnas.2122140119","article-title":"Molecular mechanism of the severe MH\/CCD mutation Y522S in skeletal ryanodine receptor (RyR1) by cryo-EM","volume":"119","author":"Iyer","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1002\/humu.22056","article-title":"Clinical and genetic findings in a large cohort of patients with ryanodine receptor 1 gene-associated myopathies","volume":"33","author":"Klein","year":"2012","journal-title":"Hum. Mutat."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/nrneurol.2017.191","article-title":"Congenital myopathies: Disorders of excitation\u2013contraction coupling and muscle contraction","volume":"14","author":"Jungbluth","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1086\/342719","article-title":"Mutations of the Selenoprotein N Gene, Which Is Implicated in Rigid Spine Muscular Dystrophy, Cause the Classical Phenotype of Multiminicore Disease: Reassessing the Nosology of Early-Onset Myopathies","volume":"71","author":"Ferreiro","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00401-012-1019-z","article-title":"Skeletal muscle \u03b1-actin diseases (actinopathies): Pathology and mechanisms","volume":"125","author":"Nowak","year":"2013","journal-title":"Acta Neuropathol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/ana.25144","article-title":"Dysfunctional sarcomere contractility contributes to muscle weakness in ACTA1-related nemaline myopathy (NEM3)","volume":"83","author":"Joureau","year":"2018","journal-title":"Ann. Neurol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"112906","DOI":"10.1016\/j.yexcr.2021.112906","article-title":"Defining and identifying satellite cell-opathies within muscular dystrophies and myopathies","volume":"411","author":"Ganassi","year":"2022","journal-title":"Exp. Cell Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/j.bbagen.2009.03.002","article-title":"Selenoprotein function and muscle disease","volume":"1790","author":"Lescure","year":"2009","journal-title":"Biochim. Biophys. Acta (BBA)\u2014Gen. Subjects"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Castets, P., Maugenre, S., Gartioux, C., Rederstorff, M., Krol, A., Lescure, A., Tajbakhsh, S., Allamand, V., and Guicheney, P. (2009). Selenoprotein N is dynamically expressed during mouse development and detected early in muscle precursors. BMC Dev. Biol., 9.","DOI":"10.1186\/1471-213X-9-46"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ceca.2017.05.001","article-title":"Endoplasmic reticulum-resident selenoproteins as regulators of calcium signaling and homeostasis","volume":"70","author":"Pitts","year":"2018","journal-title":"Cell Calcium"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s11910-012-0255-x","article-title":"Congenital Myopathies: An Update","volume":"12","author":"Nance","year":"2012","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s13311-018-00674-4","article-title":"Diagnosis and Treatment of Mitochondrial Myopathies","volume":"15","author":"Ahmed","year":"2018","journal-title":"Neurotherapeutics"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"5386","DOI":"10.1074\/jbc.R117.809194","article-title":"Mitochondrial energy generation disorders: Genes, mechanisms, and clues to pathology","volume":"294","author":"Frazier","year":"2019","journal-title":"J. Biol. Chem."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"100942","DOI":"10.1016\/j.molmet.2020.01.006","article-title":"Two genomes, one cell: Mitochondrial-nuclear coordination via epigenetic pathways","volume":"38","author":"Wiese","year":"2020","journal-title":"Mol. Metab."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"6715","DOI":"10.1073\/pnas.77.11.6715","article-title":"Maternal inheritance of human mitochondrial DNA","volume":"77","author":"Giles","year":"1980","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/emboj.2012.300","article-title":"OXPHOS mutations and neurodegeneration","volume":"32","author":"Koopman","year":"2012","journal-title":"EMBO J."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.bbabio.2009.09.005","article-title":"Mitochondrial DNA mutations and human disease","volume":"1797","author":"Tuppen","year":"2010","journal-title":"Biochim. Biophys. Acta (BBA)\u2014Bioenerg."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/molehr\/gau090","article-title":"Mitochondrial DNA disease and developmental implications for reproductive strategies","volume":"21","author":"Burgstaller","year":"2015","journal-title":"MHR Basic Sci. Reprod. Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1001\/archneur.63.12.1701","article-title":"Muscle Phenotype and Mutation Load in 51 Persons With the 3243A>G Mitochondrial DNA Mutation","volume":"63","author":"Jeppesen","year":"2006","journal-title":"Arch Neurol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"e4790","DOI":"10.7717\/peerj.4790","article-title":"Understanding mitochondrial myopathies: A review","volume":"6","author":"Ahuja","year":"2018","journal-title":"PeerJ"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Baldacci, J., Calderisi, M., Fiorillo, C., Santorelli, F.M., and Rubegni, A. (2022). Automatic Recognition of Ragged Red Fibers in Muscle Biopsy from Patients with Mitochondrial Disorders. Healthcare, 10.","DOI":"10.3390\/healthcare10030574"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3233\/JND-180308","article-title":"Current Classification and Management of Inflammatory Myopathies","volume":"5","author":"Schmidt","year":"2018","journal-title":"J. Neuromuscul. Dis."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Finsterer, J. (2020). Update Review about Metabolic Myopathies. Life, 10.","DOI":"10.3390\/life10040043"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Schirinzi, E., Ricci, G., Torri, F., Mancuso, M., and Siciliano, G. (2023). Biomolecules of Muscle Fatigue in Metabolic Myopathies. Biomolecules, 14.","DOI":"10.3390\/biom14010050"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1080\/14737175.2018.1550360","article-title":"An update on diagnosis and therapy of metabolic myopathies","volume":"18","author":"Finsterer","year":"2018","journal-title":"Expert. Rev. Neurother."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Iglesias, P. (2025). Muscle in Endocrinology: From Skeletal Muscle Hormone Regulation to Myokine Secretion and Its Implications in Endocrine\u2013Metabolic Diseases. J. Clin. Med., 14.","DOI":"10.3390\/jcm14134490"},{"key":"ref_74","first-page":"130","article-title":"Endocrine myopathies: Clinical and histopathological features of the major forms","volume":"39","author":"Rodolico","year":"2020","journal-title":"Acta Myol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0733-8619(18)30862-4","article-title":"Endocrine myopathies","volume":"6","author":"Ruff","year":"1988","journal-title":"Neurol. Clin."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S1699-258X(08)72464-1","article-title":"Inflammatory Myopathies. Dermatomyositis, Polymyositis, and Inclusion Body Myositis","volume":"4","year":"2008","journal-title":"Reumatol. Cl\u00ednica"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.7196\/SAMJ.2015.v105i12.10226","article-title":"Meeting the challenges in the diagnosis of inflammatory myopathies","volume":"105","author":"Manie","year":"2015","journal-title":"S. Afr. Med. J."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/nrcardio.2012.145","article-title":"Altered sarcoplasmic reticulum calcium cycling\u2014Targets for heart failure therapy","volume":"9","author":"Kho","year":"2012","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1126\/science.1071362","article-title":"Amphiphysin 2 (Bin1) and T-Tubule Biogenesis in Muscle","volume":"297","author":"Lee","year":"2002","journal-title":"Science"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"G\u00f3mez-Oca, R., Cowling, B.S., and Laporte, J. (2021). Common Pathogenic Mechanisms in Centronuclear and Myotubular Myopathies and Latest Treatment Advances. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222111377"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s40478-021-01287-3","article-title":"RyR1-related myopathy mutations in ATP and calcium binding sites impair channel regulation","volume":"9","author":"Yuan","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"104972","DOI":"10.1016\/j.isci.2022.104972","article-title":"Sarco(endo)plasmic reticulum Ca2+-ATPase function is impaired in skeletal and cardiac muscles from young DBA\/2J mdx mice","volume":"25","author":"Cleverdon","year":"2022","journal-title":"iScience"},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Mareedu, S., Million, E.D., Duan, D., and Babu, G.J. (2021). Abnormal Calcium Handling in Duchenne Muscular Dystrophy: Mechanisms and Potential Therapies. Front Physiol., 12.","DOI":"10.3389\/fphys.2021.647010"},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Hern\u00e1ndez-Ochoa, E.O., Pratt, S.J.P., Lovering, R.M., and Schneider, M.F. (2016). Critical Role of Intracellular RyR1 Calcium Release Channels in Skeletal Muscle Function and Disease. Front. Physiol., 6.","DOI":"10.3389\/fphys.2015.00420"},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Law, M.L., Cohen, H., Martin, A.A., Angulski, A.B.B., and Metzger, J.M. (2020). Dysregulation of Calcium Handling in Duchenne Muscular Dystrophy-Associated Dilated Cardiomyopathy: Mechanisms and Experimental Therapeutic Strategies. J. Clin. Med., 9.","DOI":"10.3390\/jcm9020520"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s13311-018-00677-1","article-title":"Ryanodine Receptor 1-Related Myopathies: Diagnostic and Therapeutic Approaches","volume":"15","author":"Lawal","year":"2018","journal-title":"Neurotherapeutics"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.nmd.2017.09.009","article-title":"Compound heterozygous RYR1 mutations in a preterm with arthrogryposis multiplex congenita and prenatal CNS bleeding","volume":"28","author":"Brackmann","year":"2018","journal-title":"Neuromuscul. Disord."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s40478-016-0392-6","article-title":"Review of RyR1 pathway and associated pathomechanisms","volume":"4","author":"Witherspoon","year":"2016","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"fcac224","DOI":"10.1093\/braincomms\/fcac224","article-title":"Targeted transcript analysis in muscles from patients with genetically diverse congenital myopathies","volume":"4","author":"Bachmann","year":"2022","journal-title":"Brain Commun."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"dmm050720","DOI":"10.1242\/dmm.050720","article-title":"Dominantly inherited muscle disorders: Understanding their complexity and exploring therapeutic approaches","volume":"17","author":"Findlay","year":"2024","journal-title":"Dis. Model. Mech."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"e261","DOI":"10.1002\/mco2.261","article-title":"Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implications","volume":"4","author":"Zhong","year":"2023","journal-title":"Medcomm"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"e202313515","DOI":"10.1085\/jgp.202313515","article-title":"Stable oxidative posttranslational modifications alter the gating properties of RyR1","volume":"156","author":"Steinz","year":"2024","journal-title":"J. Gen. Physiol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1073\/pnas.0711074105","article-title":"Remodeling of ryanodine receptor complex causes \u201cleaky\u201d channels: A molecular mechanism for decreased exercise capacity","volume":"105","author":"Bellinger","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1017\/erm.2014.17","article-title":"Dysregulation of calcium homeostasis in muscular dystrophies","volume":"16","author":"Aldanondo","year":"2014","journal-title":"Expert Rev. Mol. Med."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Lian, D., Chen, M.-M., Wu, H., Deng, S., and Hu, X. (2022). The Role of Oxidative Stress in Skeletal Muscle Myogenesis and Muscle Disease. Antioxidants, 11.","DOI":"10.3390\/antiox11040755"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1007\/s00204-023-03562-9","article-title":"Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging","volume":"97","author":"Jomova","year":"2023","journal-title":"Arch. Toxicol."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Kowalczyk, P., Sulejczak, D., Kleczkowska, P., Bukowska-O\u015bko, I., Kucia, M., Popiel, M., Wietrak, E., Kramkowski, K., Wrzosek, K., and Kaczy\u0144ska, K. (2021). Mitochondrial Oxidative Stress\u2014A Causative Factor and Therapeutic Target in Many Diseases. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222413384"},{"key":"ref_98","first-page":"2003","article-title":"Oxidative stress, mitochondrial damage and neurodegenerative diseases","volume":"8","author":"Guo","year":"2013","journal-title":"Neural Regen. Res."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/S0891-5849(03)00141-2","article-title":"Patients with dystrophinopathy show evidence of increased oxidative stress","volume":"34","author":"Rodriguez","year":"2003","journal-title":"Free Radic. Biol. Med."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1474-9726.2006.00213.x","article-title":"Age-related impairment of mesenchymal progenitor cell function","volume":"5","author":"Stolzing","year":"2006","journal-title":"Aging Cell"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1046\/j.1471-4159.1998.71020784.x","article-title":"Muscular Dystrophy in mdx Mice Despite Lack of Neuronal Nitric Oxide Synthase","volume":"71","author":"Chao","year":"1998","journal-title":"J. Neurochem."},{"key":"ref_102","unstructured":"Cohen, B., Chinnery, P., and Copeland, W. (2024). POLG-Related Disorders. GeneReviews [Internet], University of Washington."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"21590","DOI":"10.1074\/jbc.M109.070169","article-title":"Peroxisome Proliferator-activated Receptor \u03b3 Co-activator 1\u03b1 (PGC-1\u03b1) and Sirtuin 1 (SIRT1) Reside in Mitochondria","volume":"285","author":"Aquilano","year":"2010","journal-title":"J. Biol. Chemistry."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Abu Shelbayeh, O., Arroum, T., Morris, S., and Busch, K.B. (2023). PGC-1\u03b1 Is a Master Regulator of Mitochondrial Lifecycle and ROS Stress Response. Antioxidants, 12.","DOI":"10.3390\/antiox12051075"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.yjmcc.2010.09.021","article-title":"The PGC-1 cascade as a therapeutic target for heart failure","volume":"51","author":"Schilling","year":"2011","journal-title":"J. Mol. Cell Cardiol."},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Ribeiro, F., Di Geronimo, B., Cacciani, N., Widgren, A., Hedstr\u00f6m, Y., Moriscot, A.S., and Larsson, L. (2025). Myosin Post-translational Modifica-tions Associated with Critical Illness Myopathy. medRxiv.","DOI":"10.1101\/2025.08.18.25333907"},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Tulangekar, A., and Sztal, T.E. (2021). Inflammation in Duchenne Muscular Dystrophy\u2013Exploring the Role of Neutrophils in Muscle Damage and Regeneration. Biomedicines, 9.","DOI":"10.3390\/biomedicines9101366"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"2521270","DOI":"10.1080\/09540105.2025.2521270","article-title":"Obesity and breast cancer: Exploring the nexus of chronic inflammation, metabolic dysregulation, and nutritional strategies","volume":"36","author":"Carella","year":"2025","journal-title":"Food Agric. Immunol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/nm.2807","article-title":"Mechanisms of fibrosis: Therapeutic translation for fibrotic disease","volume":"18","author":"Wynn","year":"2012","journal-title":"Nat. Med."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0022-510X(70)90002-X","article-title":"Regeneration of muscle in Duchenne muscular dystrophy: An electron microscope study","volume":"11","author":"Mastaglia","year":"1970","journal-title":"J. Neurol. Sci."},{"key":"ref_111","first-page":"16","article-title":"Activation of NF-kappaB pathway in Duchenne muscular dystrophy: Relation to age","volume":"30","author":"Messina","year":"2011","journal-title":"Acta Myol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1007\/s00109-008-0373-8","article-title":"Nuclear factor-kappa B signaling in skeletal muscle atrophy","volume":"86","author":"Li","year":"2008","journal-title":"J. Mol. Med."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/path.2277","article-title":"Cellular and molecular mechanisms of fibrosis","volume":"214","author":"Wynn","year":"2008","journal-title":"J. Pathol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"965631","DOI":"10.1155\/2014\/965631","article-title":"Understanding the Process of Fibrosis in Duchenne Muscular Dystrophy","volume":"2014","author":"Kharraz","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Simancas-Racines, D., Rom\u00e1n-Galeano, N.M., Verde, L., Annunziata, G., Marchetti, M., Matos, A., Campuzano-Donoso, M., Reytor-Gonz\u00e1lez, C., Muscogiuri, G., and Barrea, L. (2025). Targeting Cytokine Dysregulation in Psoriasis: The Role of Dietary Interventions in Modulating the Immune Response. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26072895"},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Wang, X., and Zhou, L. (2022). The Many Roles of Macrophages in Skeletal Muscle Injury and Repair. Front. Cell Dev. Biol., 10.","DOI":"10.3389\/fcell.2022.952249"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"e20190103","DOI":"10.1084\/jem.20190103","article-title":"Transforming growth factor\u2013\u03b2 in tissue fibrosis","volume":"217","author":"Frangogiannis","year":"2020","journal-title":"J. Exp. Med."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1016\/j.cell.2023.07.036","article-title":"TGF-\u03b2 signaling in health and disease","volume":"186","author":"Sheppard","year":"2023","journal-title":"Cell"},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Liu, D., Zhong, Z., and Karin, M. (2022). NF-\u03baB: A Double-Edged Sword Controlling Inflammation. Biomedicines, 10.","DOI":"10.3390\/biomedicines10061250"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1002\/jcsm.13241","article-title":"Post-translational regulation of muscle growth, muscle aging and sarcopenia","volume":"14","author":"Zhong","year":"2023","journal-title":"J. Cachex-Sarcopenia Muscle"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12576-020-00768-9","article-title":"The ubiquitin\u2013proteasome system in regulation of the skeletal muscle homeostasis and atrophy: From basic science to disorders","volume":"70","author":"Kitajima","year":"2020","journal-title":"J. Physiol. Sci."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S1474-4422(12)70204-1","article-title":"The myotonic dystrophies: Molecular, clinical, and therapeutic challenges","volume":"11","author":"Udd","year":"2012","journal-title":"Lancet Neurol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"797","DOI":"10.4103\/0028-3886.325313","article-title":"Challenges and Advances in Molecular Diagnosis of Myopathies and Dystrophies in Perspective of Their Use in Developing Countries: Past, Present, and Future","volume":"69","author":"Attri","year":"2021","journal-title":"Neurol. India"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.nmd.2014.11.001","article-title":"The 2015 version of the gene table of monogenic neuromuscular disorders (nuclear genome)","volume":"24","author":"Kaplan","year":"2014","journal-title":"Neuromuscul. Disord."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/ng.499","article-title":"Exome sequencing identifies the cause of a mendelian disorder","volume":"42","author":"Ng","year":"2009","journal-title":"Nat. Genet."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.celrep.2014.12.015","article-title":"Accelerating Novel Candidate Gene Discovery in Neurogenetic Disorders via Whole-Exome Sequencing of Prescreened Multiplex Consanguineous Families","volume":"10","author":"Alazami","year":"2015","journal-title":"Cell Rep."},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Brlek, P., Buli\u0107, L., Bra\u010di\u0107, M., Proji\u0107, P., \u0160karo, V., Shah, N., Shah, P., and Primorac, D. (2024). Implementing Whole Genome Sequencing (WGS) in Clinical Practice: Advantages, Challenges, and Future Perspectives. Cells, 13.","DOI":"10.3390\/cells13060504"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"e000990","DOI":"10.1136\/bmjno-2024-000990","article-title":"Long-read sequencing for diagnosis of genetic myopathies","volume":"7","author":"Yeow","year":"2025","journal-title":"BMJ Neurol. Open"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1055\/s-0039-1688446","article-title":"Next-Generation Sequencing and Emerging Technologies","volume":"45","author":"Kumar","year":"2019","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s40478-021-01201-x","article-title":"An update on the neurological short tandem repeat expansion disorders and the emergence of long-read sequencing diagnostics","volume":"9","author":"Chintalaphani","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/s41576-024-00696-z","article-title":"Sequence composition changes in short tandem repeats: Heterogeneity, detection, mechanisms and clinical implications","volume":"25","author":"Dolzhenko","year":"2024","journal-title":"Nat. Rev. Genet."},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"The Scottish Myotonic Dystrophy Consortium, Cumming, S.A., Hamilton, M.J., Robb, Y., Gregory, H., McWilliam, C., Cooper, A., Adam, B., McGhie, J., and Hamilton, G. (2018). De novo repeat interruptions are associated with reduced somatic instability and mild or absent clinical features in myotonic dystrophy type 1. Eur. J. Hum. Genet., 26, 1635\u20131647.","DOI":"10.1038\/s41431-018-0156-9"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"149587","DOI":"10.1016\/j.gene.2025.149587","article-title":"Variants of uncertain significance: At the crux of diagnostic odyssey","volume":"962","author":"Zawar","year":"2025","journal-title":"Gene"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"108529","DOI":"10.1016\/j.mrrev.2024.108529","article-title":"Decoding complexity: The role of long-read sequencing in unraveling genetic disease etiologies","volume":"795","author":"Xu","year":"2025","journal-title":"Mutat. Res. Rev. Mutat. Res."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"110842","DOI":"10.1016\/j.ygeno.2024.110842","article-title":"Advancements in long-read genome sequencing technologies and algorithms","volume":"116","author":"Espinosa","year":"2024","journal-title":"Genomics"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40246-024-00696-4","article-title":"High clinical utility of long-read sequencing for precise diagnosis of congenital adrenal hyperplasia in 322 probands","volume":"19","author":"Wang","year":"2025","journal-title":"Hum. Genom."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"e36671","DOI":"10.1097\/MD.0000000000036671","article-title":"Ethical implications of AI and robotics in healthcare: A review","volume":"102","author":"Elendu","year":"2023","journal-title":"Medicine"},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Athanasopoulou, K., Michalopoulou, V.-I., Scorilas, A., and Adamopoulos, P.G. (2025). Integrating Artificial Intelligence in Next-Generation Sequencing: Advances, Challenges, and Future Directions. Curr. Issues Mol. Biol., 47.","DOI":"10.3390\/cimb47060470"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"e13323","DOI":"10.1016\/j.heliyon.2023.e13323","article-title":"Biomarkers: Promising and valuable tools towards diagnosis, prognosis and treatment of Covid-19 and other diseases","volume":"9","author":"Bodaghi","year":"2023","journal-title":"Heliyon"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s13317-014-0063-1","article-title":"Assessment of patients with idiopathic inflammatory myopathies and isolated creatin-kinase elevation","volume":"5","author":"Iaccarino","year":"2014","journal-title":"Autoimmun. Highlights"},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"De Paepe, B. (2023). Incorporating circulating cytokines into the idiopathic inflammatory myopathy subclassification toolkit. Front. Med., 10.","DOI":"10.3389\/fmed.2023.1130614"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.mito.2019.10.005","article-title":"Growth and differentiation factor 15 as a biomarker for mitochondrial myopathy","volume":"50","author":"Poulsen","year":"2020","journal-title":"Mitochondrion"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1196\/annals.1398.050","article-title":"Chemokine Profile of Different Inflammatory Myopathies Reflects Humoral versus Cytotoxic Immune Responses","volume":"1109","author":"Creus","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1007\/s10067-025-07367-2","article-title":"The role of CXCL9, CXCL10, and CXCL13 chemokines in patients with Sj\u00f6gren\u2019s syndrome","volume":"44","author":"Hakbilen","year":"2025","journal-title":"Clin. Rheumatol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/emmm.201100133","article-title":"miRNAs as serum biomarkers for Duchen-ne muscular dystrophy","volume":"3","author":"Cacchiarelli","year":"2011","journal-title":"EMBO Mol. Med."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"10513","DOI":"10.1073\/pnas.0804549105","article-title":"Circulating microRNAs as stable blood-based markers for cancer detection","volume":"105","author":"Mitchell","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"2510961","DOI":"10.1080\/09540105.2025.2510961","article-title":"Obesity and endometrial cancer: Biological mechanisms, nutritional strategies, and clinical perspectives","volume":"36","author":"Memoli","year":"2025","journal-title":"Food Agric. Immunol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"2510951","DOI":"10.1080\/09540105.2025.2510951","article-title":"Oesophageal adenocarcinoma, obesity, and cancer: The role of nutrition in prevention and management","volume":"36","author":"Carella","year":"2025","journal-title":"Food Agric. Immunol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s12199-014-0405-7","article-title":"Three novel serum biomarkers, miR-1, miR-133a, and miR-206 for Limb-girdle muscular dystrophy, Facioscapulohumeral muscular dystrophy, and Becker muscular dystrophy","volume":"19","author":"Matsuzaka","year":"2014","journal-title":"Env. Health Prev. Med."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3233\/JND-140066","article-title":"Muscle-Derived Proteins as Serum Bi-omarkers for Monitoring Disease Progression in Three Forms of Muscular Dystrophy","volume":"2","author":"Burch","year":"2015","journal-title":"J. Neuromuscul. Dis."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41413-025-00442-z","article-title":"Current cutting-edge omics techniques on musculoskeletal tissues and diseases","volume":"13","author":"Li","year":"2025","journal-title":"Bone Res."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1038\/s41467-025-56896-6","article-title":"Human skeletal muscle fiber heterogeneity beyond myosin heavy chains","volume":"16","author":"Stocks","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"Pauper, M., Hentschel, A., Tiburcy, M., Beltran, S., Ruck, T., Schara-Schmidt, U., and Roos, A. (2025). Proteomic Profiling Towards a Better Understanding of Genetic Based Muscular Diseases: The Current Picture and a Look to the Future. Biomolecules, 15.","DOI":"10.3390\/biom15010130"},{"key":"ref_154","first-page":"209","article-title":"Endocrinologist\u2019s crucial role in metabolic dysfunction-associated steatotic liver disease: A comprehensive review","volume":"50","author":"Annunziata","year":"2025","journal-title":"Minerva Endocrinol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/MD.0b013e31829d08f9","article-title":"The Myositis Autoantibody Phenotypes of the Juvenile Idiopathic Inflammatory Myopathies","volume":"92","author":"Rider","year":"2013","journal-title":"Medicine"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1001\/jamaneurol.2018.2598","article-title":"Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies","volume":"75","author":"Mariampillai","year":"2018","journal-title":"JAMA Neurol."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/nan.12380","article-title":"Integrated classification of inflammatory myopathies","volume":"43","author":"Allenbach","year":"2017","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"ref_158","doi-asserted-by":"crossref","unstructured":"Gervasoni, J., Primiano, A., Marini, F., Sabino, A., Biancolillo, A., Calvani, R., Picca, A., Marzetti, E., Persichilli, S., and Urbani, A. (2020). Fourier-Transform Infrared Spectroscopy of Skeletal Muscle Tissue: Expanding Biomarkers in Primary Mitochondrial Myopathies. Genes, 11.","DOI":"10.3390\/genes11121522"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"10111","DOI":"10.1038\/s41598-020-66940-8","article-title":"Growth Differentiation Factor 15 is a potential biomarker of therapeutic response for TK2 deficient myopathy","volume":"10","author":"Badosa","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Montero, R., Yubero, D., Villarroya, J., Henares, D., Jou, C., Rodr\u00edguez, M.A., Ramos, F., Nascimento, A., Ortez, C.I., and Campistol, J. (2016). GDF-15 Is Elevated in Children with Mitochondrial Diseases and Is Induced by Mitochondrial Dysfunction. PLoS ONE, 11, Erratum in PLoS ONE 2016, 11, e0155172.","DOI":"10.1371\/journal.pone.0155172"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"109179","DOI":"10.1016\/j.ymgme.2025.109179","article-title":"The mitochondrial disease biomarker GDF15 is dynamic, quantifiable in saliva, and correlates with disease severity","volume":"145","author":"Huang","year":"2025","journal-title":"Mol. Genet. Metab."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s12079-022-00705-y","article-title":"Advances in studies of circulating microRNAs: Origination, transportation, and distal target regulation","volume":"17","author":"Wu","year":"2023","journal-title":"J. Cell Commun. Signal."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.nmd.2020.08.360","article-title":"247th ENMC International Workshop: Muscle magnetic resonance imaging\u2014Implementing muscle MRI as a diagnostic tool for rare genetic myopathy cohorts. Hoofddorp, The Netherlands, September 2019","volume":"30","author":"Tasca","year":"2020","journal-title":"Neuromuscul. Disord."},{"key":"ref_164","doi-asserted-by":"crossref","unstructured":"Zubair, A.S., Salam, S., Dimachkie, M.M., Machado, P.M., and Roy, B. (2023). Imaging biomarkers in the idiopathic inflammatory myopathies. Front. Neurol., 14.","DOI":"10.3389\/fneur.2023.1146015"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/s42003-024-06143-3","article-title":"Revealing myopathy spectrum: Integrating transcriptional and clinical features of human skeletal muscles with varying health conditions","volume":"7","author":"Zhong","year":"2024","journal-title":"Commun. Biol."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"e199","DOI":"10.1016\/j.lpm.2010.10.035","article-title":"Observations on the classification of the inflammatory myopathies","volume":"40","year":"2011","journal-title":"Presse Med."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"325210","DOI":"10.1155\/2009\/325210","article-title":"Duchenne and Becker Muscular Dystrophy: Contribution of a Molecular and Immunohistochemical Analysis in Diagnosis in Morocco","volume":"2009","author":"Bellayou","year":"2009","journal-title":"BioMed Res. Int."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.gene.2013.03.059","article-title":"Myotonic dystrophy type 1 (DM1): A triplet repeat expansion disorder","volume":"522","author":"Kumar","year":"2013","journal-title":"Gene"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.spen.2011.10.010","article-title":"Congenital Muscular Dystrophies: A Brief Review","volume":"18","author":"Bertini","year":"2011","journal-title":"Semin. Pediatr. Neurol."},{"key":"ref_170","first-page":"125","article-title":"Mutations in LAMA2 and CAPN3 genes associated with genetic and phenotypic heterogeneities within a single consanguineous family involving both congenital and progressive muscular dystrophies","volume":"31","author":"Salem","year":"2010","journal-title":"Biosci. Rep."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s12291-017-0688-8","article-title":"Diseases and Molecular Diagnostics: A Step Closer to Precision Medicine","volume":"32","author":"Dwivedi","year":"2017","journal-title":"Indian J. Clin. Biochem."},{"key":"ref_172","doi-asserted-by":"crossref","unstructured":"Torella, A., Zanobio, M., Zeuli, R., Del Vecchio Blanco, F., Savarese, M., Giugliano, T., Garofalo, A., Piluso, G., Politano, L., and Nigro, V. (2020). The position of nonsense mutations can predict the phenotype severity: A survey on the DMD gene. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0237803"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s11897-023-00592-3","article-title":"Cardiac Involvement in Mitochondrial Disorders","volume":"20","author":"Popoiu","year":"2023","journal-title":"Curr. Heart Fail. Rep."},{"key":"ref_174","doi-asserted-by":"crossref","unstructured":"Sgarito, G., Volpe, C., Bardari, S., Calvanese, R., China, P., Mascioli, G., Nesti, M., Pignalberi, C., Cipriani, M., and Zecchin, M. (2025). Cardiomyopathies and Arrythmias in Neuromuscular Diseases. Cardiogenetics, 15.","DOI":"10.3390\/cardiogenetics15010007"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.jacbts.2021.11.004","article-title":"Cardiovascular Disease in Duchenne Muscular Dystrophy","volume":"7","author":"Schultz","year":"2022","journal-title":"JACC Basic. Transl. Sci."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"2496499","DOI":"10.1080\/09540105.2025.2496499","article-title":"Harnessing nutrition to combat MASLD: A comprehensive guide to food-based therapeutic strategies","volume":"36","author":"Jimenez","year":"2025","journal-title":"Food Agric. Immunol."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"e70099","DOI":"10.1111\/echo.70099","article-title":"Acute Myocarditis and Inflammatory Cardiomyopathies: Insights From Cardiac Magnetic Resonance Findings","volume":"42","author":"Lauriero","year":"2025","journal-title":"Echocardiography"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"392","DOI":"10.4103\/aian.aian_1001_24","article-title":"Cardiac Magnetic Resonance Imaging Markers in Idiopathic Inflammatory Myopathy\u2014A Prospective Observational Study","volume":"28","author":"Samim","year":"2025","journal-title":"Ann. Indian Acad. Neurol."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1002\/mus.24353","article-title":"Muscle magnetic resonance imaging and histopathology in ACTA1-related congenital nemaline myopathy","volume":"50","author":"Castiglioni","year":"2014","journal-title":"Muscle Nerve"},{"key":"ref_180","doi-asserted-by":"crossref","unstructured":"Budin-Lj\u00f8sne, I., Soye, K.J., Tass\u00e9, A.M., Knoppers, B.M., and Harris, J.R. (2013). Genotype-driven recruitment: A strategy whose time has come?. BMC Med. Genom., 6.","DOI":"10.1186\/1755-8794-6-19"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2147\/DDDT.S97635","article-title":"Eteplirsen in the treatment of Duchenne muscular dystrophy","volume":"11","author":"Lim","year":"2017","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_182","doi-asserted-by":"crossref","unstructured":"Eser, G., and Topalo\u011flu, H. (2022). Current Outline of Exon Skipping Trials in Duchenne Muscular Dystrophy. Genes, 13.","DOI":"10.3390\/genes13071241"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"S303","DOI":"10.3233\/JND-210678","article-title":"Gene Therapy for Duchenne Muscular Dystrophy","volume":"8","author":"Elangkovan","year":"2021","journal-title":"J. Neuromuscul. Dis."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1089\/hum.2018.012","article-title":"Micro-Dystrophin Gene Therapy Goes Systemic in Duchenne Muscular Dystrophy Patients","volume":"29","author":"Duan","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/mt.2009.256","article-title":"Evidence for the Failure of Adeno-associated Virus Serotype 5 to Package a Viral Genome \u2265 8.2 kb","volume":"18","author":"Lai","year":"2010","journal-title":"Mol. Ther."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.omtm.2017.06.006","article-title":"A Five-Repeat Micro-Dystrophin Gene Ameliorated Dystrophic Phenotype in the Severe DBA\/2J-mdx Model of Duchenne Muscular Dystrophy","volume":"6","author":"Hakim","year":"2017","journal-title":"Mol. Ther.\u2014Methods Clin. Dev."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.omtn.2023.08.006","article-title":"A fleeting glimpse of functional benefit of the complete DMD gene in a large animal model of Duchenne muscular dystrophy","volume":"33","author":"Hoffman","year":"2023","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1016\/j.ymthe.2018.07.011","article-title":"Systemic AAV Micro-dystrophin Gene Therapy for Duchenne Muscular Dystrophy","volume":"26","author":"Duan","year":"2018","journal-title":"Mol. Ther."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1038\/mt.2010.94","article-title":"Widespread Muscle Expression of an AAV9 Human Mini-dystrophin Vector After Intravenous Injection in Neonatal Dystrophin-deficient Dogs","volume":"18","author":"Kornegay","year":"2010","journal-title":"Mol. Ther."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"101631","DOI":"10.1016\/j.omtm.2025.101631","article-title":"Should patients with pre-existing anti-AAV antibodies be excluded from receiving intrathecally delivered AAV vectors?","volume":"33","author":"Gray","year":"2025","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1182\/blood-2013-01-306647","article-title":"Immune responses to AAV vectors: Overcoming barriers to successful gene therapy","volume":"122","author":"Mingozzi","year":"2013","journal-title":"Blood"},{"key":"ref_192","doi-asserted-by":"crossref","unstructured":"Sarno, G., Reytor-Gonz\u00e1lez, C., Fr\u00edas-Toral, E., Campuzano-Donoso, M., Katsanos, C.S., and Simancas-Racines, D. (2025). Navigating the Weight: The Impact of Obesity on Gastrointestinal Cancer Surgery and Strategies for Improved Outcomes. Seminars in Cancer Biology, Academic Press.","DOI":"10.1016\/j.semcancer.2025.06.010"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/mt.2011.59","article-title":"Current Status of Pharmaceutical and Genetic Therapeutic Approaches to Treat DMD","volume":"19","author":"Pichavant","year":"2011","journal-title":"Mol. Ther."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1517\/21678707.2015.1088780","article-title":"Gene therapy for Duchenne muscular dystrophy","volume":"3","author":"Ramos","year":"2015","journal-title":"Expert Opin. Orphan Drugs"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.1038\/s41598-023-31481-3","article-title":"Full-length human dystrophin on human artificial chromosome compensates for mouse dystrophin deficiency in a Duchenne muscular dystrophy mouse model","volume":"13","author":"Hiramuki","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_196","doi-asserted-by":"crossref","unstructured":"Lim, K.R.Q., Yoon, C., and Yokota, T. (2018). Applications of CRISPR\/Cas9 for the Treatment of Duchenne Muscular Dystrophy. J. Pers. Med., 8.","DOI":"10.20944\/preprints201811.0018.v1"},{"key":"ref_197","unstructured":"PTC Therapeutics (2009, January 14). Safety and Efficacy Study of PTC124 in Duchenne Muscular Dystrophy, Available online: https:\/\/www.clinicaltrials.gov\/study\/NCT00264888?term=ptc124&viewType=Table&rank=3."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.jacbts.2024.12.015","article-title":"Long-Term Dystrophin Replacement Therapy in Duchenne Muscular Dystrophy Causes Cardiac Inflammation","volume":"10","author":"Forand","year":"2025","journal-title":"JACC Basic Transl. Sci."},{"key":"ref_199","doi-asserted-by":"crossref","unstructured":"Dhuri, K., Bechtold, C., Quijano, E., Pham, H., Gupta, A., Vikram, A., and Bahal, R. (2020). Antisense Oligonucleotides: An Emerging Area in Drug Discovery and Development. J. Clin. Med., 9.","DOI":"10.3390\/jcm9062004"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"e1594","DOI":"10.1002\/wrna.1594","article-title":"The powerful world of antisense oligonucleotides: From bench to bedside","volume":"11","author":"Quemener","year":"2020","journal-title":"WIREs RNA"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1016\/j.ymthe.2025.04.038","article-title":"Clinical applications of exon-skipping antisense oligonucleotides in neuromuscular diseases","volume":"33","author":"Aguti","year":"2025","journal-title":"Mol. Ther."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/sj.gt.3302800","article-title":"Antisense oligonucleotide-induced exon skipping restores dystrophin expression in vitro in a canine model of DMD","volume":"13","author":"McClorey","year":"2006","journal-title":"Gene Ther."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/S1474-4422(09)70211-X","article-title":"Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: A single-blind, placebo-controlled, dose-escalation, proof-of-concept study","volume":"8","author":"Kinali","year":"2009","journal-title":"Lancet Neurol."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.ajpath.2012.04.006","article-title":"Long-Term Rescue of Dystrophin Expression and Improvement in Muscle Pathology and Function in Dystrophic mdx Mice by Peptide-Conjugated Morpholino","volume":"181","author":"Wu","year":"2012","journal-title":"Am. J. Pathol."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"338","DOI":"10.20517\/jtgg.2025.57","article-title":"An appraisal of emerging dystrophin restoration therapies in Duchenne muscular dystrophy","volume":"9","author":"Batley","year":"2025","journal-title":"J. Transl. Genet. Genom."},{"key":"ref_206","doi-asserted-by":"crossref","unstructured":"Wilton-Clark, H., and Yokota, T. (2023). Recent Trends in Antisense Therapies for Duchenne Muscular Dystrophy. Pharmaceutics, 15.","DOI":"10.20944\/preprints202301.0139.v1"},{"key":"ref_207","doi-asserted-by":"crossref","unstructured":"Aupy, P., Echevarr\u00eda, L., Relizani, K., and Goyenvalle, A. (2017). The Use of Tricyclo-DNA Oligomers for the Treatment of Genetic Disorders. Biomedicines, 6.","DOI":"10.3390\/biomedicines6010002"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s43856-023-00419-1","article-title":"Possibilities and limitations of antisense oligonucleotide therapies for the treatment of monogenic disorders","volume":"4","author":"Lauffer","year":"2024","journal-title":"Commun. Med."},{"key":"ref_209","doi-asserted-by":"crossref","unstructured":"Sardone, V., Zhou, H., Muntoni, F., Ferlini, A., and Falzarano, M. (2017). Antisense Oligonucleotide-Based Therapy for Neuromuscular Disease. Molecules, 22.","DOI":"10.3390\/molecules22040563"},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.tips.2025.01.005","article-title":"Emerging mechanisms and therapeutics in inflammatory muscle diseases","volume":"46","author":"Wischnewski","year":"2025","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1474-4422(18)30025-5","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 2: Respiratory, cardiac, bone health, and orthopaedic management","volume":"17","author":"Birnkrant","year":"2018","journal-title":"Lancet Neurol."},{"key":"ref_212","doi-asserted-by":"crossref","unstructured":"Yao, S., Chen, Z., Yu, Y., Zhang, N., Jiang, H., Zhang, G., Zhang, Z., and Zhang, B. (2021). Current Pharmacological Strategies for Duchenne Muscular Dystrophy. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.689533"},{"key":"ref_213","first-page":"1237","article-title":"Restoration of muscle strength in dystrophic muscle by angiotensin-1-7 through inhibition of TGF-\u03b2 signalling","volume":"23","author":"Pessina","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"ref_214","first-page":"e135703","article-title":"TGF-\u03b2\u2013driven muscle degeneration and failed regeneration underlie disease onset in a DMD mouse model","volume":"5","author":"Novak","year":"2020","journal-title":"J. Clin. Investig."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"e3027","DOI":"10.5867\/medwave.2025.02.3027","article-title":"Mediterranean diet and breast cancer: A narrative review","volume":"25","author":"Zambrano","year":"2025","journal-title":"Medwave"},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1586\/14779072.5.1.99","article-title":"Cardiomyopathy of Duchenne muscular dystrophy: Pathogenesis and prospect of membrane sealants as a new therapeutic approach","volume":"5","author":"Townsend","year":"2007","journal-title":"Expert. Rev. Cardiovasc. Ther."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ajpath.2010.11.027","article-title":"Long-Term Blocking of Calcium Channels in mdx Mice Results in Differential Effects on Heart and Skeletal Muscle","volume":"178","author":"Blain","year":"2011","journal-title":"Am. J. Pathol."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/mus.22047","article-title":"CINRG pilot trial of coenzyme Q10 in steroid-treated duchenne muscular dystrophy","volume":"44","author":"Spurney","year":"2011","journal-title":"Muscle Nerve"},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.biocel.2014.01.020","article-title":"Coenzyme Q10 as a therapy for mitochondrial disease","volume":"49","author":"Hargreaves","year":"2014","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.nmd.2019.10.008","article-title":"Long-term data with idebenone on respiratory function outcomes in patients with Duchenne muscular dystrophy","volume":"30","author":"Servais","year":"2020","journal-title":"Neuromuscul. Disord."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.clnu.2012.06.001","article-title":"N-Acetylcysteine treatment reduces TNF-\u03b1 levels and myonecrosis in diaphragm muscle of mdx mice","volume":"32","author":"Ferretti","year":"2013","journal-title":"Clin. Nutr."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1073\/pnas.0908540107","article-title":"Leaky RyR2 trigger ventricular arrhythmias in Duchenne muscular dystrophy","volume":"107","author":"Fauconnier","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_223","doi-asserted-by":"crossref","unstructured":"Schleidgen, S., Dederer, H.-G., Sgodda, S., Cravcisin, S., L\u00fcneburg, L., Cantz, T., and Heinemann, T. (2020). Human germline editing in the era of CRISPR-Cas: Risk and uncertainty, inter-generational responsibility, therapeutic legitimacy. BMC Med. Ethics, 21.","DOI":"10.1186\/s12910-020-00487-1"},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s41649-018-0056-x","article-title":"Risks and benefits of human germline genome editing: An ethical analysis","volume":"10","author":"Rubeis","year":"2018","journal-title":"Asian Bioeth. Rev."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/s41434-023-00419-9","article-title":"The estimated annual financial impact of gene therapy in the United States","volume":"30","author":"Wong","year":"2023","journal-title":"Gene Ther."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/S2213-8587(23)00164-X","article-title":"The case for precision medicine in the prevention, diagnosis, and treatment of cardiometabolic diseases in low-income and middle-income countries","volume":"11","author":"Misra","year":"2023","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1089\/hum.2022.190","article-title":"Microdystrophin Expression as a Surrogate Endpoint for Duchenne Muscular Dystrophy Clinical Trials","volume":"34","author":"Chamberlain","year":"2023","journal-title":"Hum. Gene Ther."},{"key":"ref_228","first-page":"69","article-title":"Integrating Artificial Intelligence-Driven Wearable Technology in Oncology Decision-Making: A Narrative Review","volume":"103","author":"Birla","year":"2025","journal-title":"Oncology"},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/cts.12884","article-title":"Precision Medicine, AI, and the Future of Personalized Health Care","volume":"14","author":"Johnson","year":"2021","journal-title":"Clin. Transl. Sci."},{"key":"ref_230","doi-asserted-by":"crossref","unstructured":"Auger, S.D., and Scott, G. (2025). Machine learning detects hidden treatment response patterns only in the presence of comprehensive clinical phenotyping. PLoS ONE, 20.","DOI":"10.1371\/journal.pone.0334858"},{"key":"ref_231","doi-asserted-by":"crossref","unstructured":"Bangeas, A., Poulidou, V., Liampas, I., Marogianni, C., Aloizou, A.-M., Tsouris, Z., and Siokas, V. (2025). Advances in Management of Mito-chondrial Myopathies. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26115411"},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"5709","DOI":"10.1038\/s41467-025-61239-6","article-title":"Biotechnological approaches and therapeutic po-tential of mitochondria transfer and transplantation","volume":"16","author":"Kubat","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"104019","DOI":"10.1016\/j.redox.2026.104019","article-title":"Intercellular mitochondrial transfer rewires redox signaling and metabolic plasticity: Mechanisms, disease relevance and therapeutic frontiers","volume":"90","author":"Wang","year":"2026","journal-title":"Redox Biol."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/rmb2.12356","article-title":"Mitochondrial replacement by genome transfer in human oocytes: Efficacy, concerns, and legality","volume":"20","author":"Yamada","year":"2021","journal-title":"Reprod. Med. Biol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/3\/1392\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T13:05:28Z","timestamp":1769778328000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/3\/1392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":234,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["ijms27031392"],"URL":"https:\/\/doi.org\/10.3390\/ijms27031392","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]}}}